April 4, 2024
The ALS drug, Relyvrio, will no longer be available to new patients as of Thursday.Mandatory Credit: Amylyx Pharmaceuticals/AP/File via CNN Newsource
HCTRA - Keep It Moving
GM Boasts Strong Sales June 2025